ArticleGenes & diseases2023

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer.

Ying Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.